Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Change in Accured Expenses: 2013-2019

Historic Change in Accured Expenses for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to $968,000.

  • Soleno Therapeutics' Change in Accured Expenses rose 528.57% to $968,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.7 million, marking a year-over-year increase of 423.05%. This contributed to the annual value of $1.6 million for FY2024, which is 12.40% up from last year.
  • Soleno Therapeutics' Change in Accured Expenses amounted to $968,000 in Q4 2019, which was up 119.00% from $442,000 recorded in Q3 2019.
  • Over the past 5 years, Soleno Therapeutics' Change in Accured Expenses peaked at $968,000 during Q4 2019, and registered a low of -$317,000 during Q1 2016.
  • In the last 3 years, Soleno Therapeutics' Change in Accured Expenses had a median value of $147,500 in 2018 and averaged $160,167.
  • Within the past 5 years, the most significant YoY rise in Soleno Therapeutics' Change in Accured Expenses was 3,950.00% (2018), while the steepest drop was 414.29% (2018).
  • Over the past 5 years, Soleno Therapeutics' Change in Accured Expenses (Quarterly) stood at $467,626 in 2015, then skyrocketed by 49.80% to $700,486 in 2016, then tumbled by 100.57% to -$4,000 in 2017, then surged by 3,950.00% to $154,000 in 2018, then skyrocketed by 528.57% to $968,000 in 2019.
  • Its Change in Accured Expenses stands at $968,000 for Q4 2019, versus $442,000 for Q3 2019 and $81,000 for Q2 2019.